DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Wortman BG, Creutzberg CL, Putter H. et al; PORTEC Study Group.
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Br J Cancer 2018;
119 (09) 1067-1074
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.